Emerging evidence over the past 15 years has led researchers to believe that genetics plays a far greater role in Parkinson's disease (PD) than was once thought. Today, scientists are digging deeper than ever before, with the hope of translating a greater understanding of PD genetics into treatment breakthroughs for everyone with the disease.
On Tuesday, September 18th at 12pm EST, The Michael J. Fox Foundation (MJFF) will present a webinar on PD genetics and its role in forming the building blocks for next-generation treatments for the disease.
We invite you to register to participate!
The webinar will:
- Provide an introduction to genetics and the inner-workings of DNA.
- Discuss the latest in genetic changes associated with Parkinson’s.
- Answer participants’ questions live.
You can learn more ahead of next Tuesday’s webinar by checking out MJFF resources online. Visit our general genetics page, or learn more about promising genetic targets for PD such as LRRK2 and alpha-synuclein. You can also listen to a podcast addressing some of the ethical questions surrounding the decision to get genetically tested.
You’ll also notice the new format for our Hot Topics series. We heard from you, and we’ve adopted an easier to use, more holistic experience. Now, you can:
- Listen and watch accompanying slides directly from your computer. No phone necessary!
- Type your questions directly into an easy-to-use interface. A moderator will choose the most relevant ones for the Hot Topics Q&A.
See you on the 18th!